Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $220,076 - $306,332
-2,740 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $165,742 - $267,150
2,740 New
2,740 $222,000
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $325,886 - $453,468
-5,478 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $342,868 - $604,223
5,478 New
5,478 $350,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.82B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Shen Neil Nanpeng Portfolio

Follow Shen Neil Nanpeng and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shen Neil Nanpeng, based on Form 13F filings with the SEC.

News

Stay updated on Shen Neil Nanpeng with notifications on news.